Explain
| Finding | Details |
|---|---|
| Right-sided CVC | Tip in SVC - correct position |
| Cardiomegaly | CT ratio > 0.5 |
| Left lower zone opacity | Consolidation, collapse, or effusion |
| Blunted costophrenic angles | Bilateral pleural effusions (small-moderate) |
| Increased bronchovascular markings | Pulmonary venous congestion |
Note: This is a radiological description for educational purposes. Clinical correlation with the patient's history, examination, echocardiography, and laboratory investigations (BNP, troponin, CBC) is essential for a definitive diagnosis.
Approach to loose stools with management as per latest guidelines and indication of antibiotics in loose stool
"acute diarrhea" AND management AND guidelines
acute diarrhea management guidelines 2024 2025 antibiotic indications WHO
https://pmc.ncbi.nlm.nih.gov/articles/PMC6609748
| Flag | Suggests |
|---|---|
| Bloody/mucoid stool | Invasive bacterial colitis (Shigella, Campylobacter, STEC) |
| High fever (>38.5°C) | Bacterial or amoebic infection |
| Severe dehydration | Cholera, severe bacterial diarrhea |
| >10 stools/day | Severe infection, cholera |
| Symptoms >3 days | Less likely viral; consider bacterial/parasitic |
| Age >70 or immunocompromised | High-risk for complications |
| Abdominal pain out of proportion | Rule out mesenteric ischemia |
| Degree | Features | Plan |
|---|---|---|
| No dehydration | Normal skin turgor, eyes, fontanelle, urine output | Plan A - ORS at home |
| Some/Mild-Moderate | Sunken eyes, reduced skin turgor, restless/irritable, thirsty | Plan B - ORS 75 mL/kg over 4 hrs |
| Severe | Very sunken eyes, poor skin turgor, lethargic/unconscious, no urine | Plan C - IV fluids urgently (Ringer's Lactate or Normal Saline) |
10 stools in 24 hours
| Agent | Indication | Notes |
|---|---|---|
| Loperamide | Watery non-bloody diarrhea, adults | Antimotility; reduces stool frequency; do NOT use in bloody diarrhea or children <2 yrs; avoid if fever present |
| Racecadotril | Secretory diarrhea (children) | Antisecretory; safer alternative to loperamide in children |
| Ondansetron | Associated vomiting | Helps oral rehydration; proven in children |
| Probiotics | Adjunct in acute diarrhea | Modest reduction in duration; Lactobacillus GG and S. boulardii have best evidence |
Key principle: Most acute diarrhea is self-limiting and viral. Routine antibiotic use is NOT recommended. Antibiotics are indicated only in specific situations.
| Situation | Rationale |
|---|---|
| Dysentery (bloody diarrhea + fever) | Likely Shigella, Campylobacter, or invasive organism; empiric antibiotics reduce duration |
| Cholera (watery, rice-water stool, endemic area) | Reduces fluid losses and duration significantly |
| Severe infectious diarrhea (>6-10 stools/day, systemic toxicity, hospitalized) | High bacterial load; intervention beneficial |
| Immunocompromised patient (HIV, transplant, on steroids, malignancy) | Risk of bacteremia and dissemination is high |
| Traveler's diarrhea - moderate/severe | Symptoms interfering with travel/activities; duration shortened by ~24 hrs with antibiotics |
| Confirmed Shigella | Always treat; reduces duration, complications, and shedding |
| Confirmed Vibrio cholerae | Always treat |
| Persistent diarrhea with suspected Giardia/amoeba | Metronidazole empirically if antigen tests positive or clinical suspicion high |
| C. difficile infection | Treat with oral vancomycin or fidaxomicin (NOT metronidazole - no longer first-line per AGA 2026) |
| Elderly patients (>65) with significant diarrhea | Higher risk of complications; lower threshold |
| Underlying cardiac/valvular disease | Risk of Salmonella bacteremia |
| Antibiotic | Dose | Duration | Notes |
|---|---|---|---|
| Azithromycin | 500 mg OD or 1000 mg single dose | 3 days | Preferred first-line now (due to rising fluoroquinolone resistance); drug of choice in pregnancy and travel to South/Southeast Asia |
| Ciprofloxacin | 500 mg BD | 3 days | Historically first-line; resistance increasing, especially for Campylobacter; use with caution |
| Levofloxacin | 500 mg OD | 3 days | Alternative fluoroquinolone |
| Rifaximin | 200 mg TDS | 3 days | Non-systemic; excellent for traveler's diarrhea (non-dysenteric); NOT for invasive/bloody diarrhea |
| Metronidazole | 400-500 mg TDS | 5-7 days | For Giardia, Amoeba, anaerobes |
Note on fluoroquinolones: Resistance has increased dramatically worldwide, particularly in South Asia. The 2019 Korean guideline on antibiotic use in gastroenteritis and IDSA 2017 guidelines both note fluoroquinolone resistance concerns. Azithromycin is now the preferred empiric agent in most regions.
| Pathogen | Drug of Choice |
|---|---|
| Shigella | Azithromycin (or ciprofloxacin if sensitive) x 3 days |
| Campylobacter | Azithromycin x 3 days (high quinolone resistance) |
| Salmonella typhi | Azithromycin or fluoroquinolone x 7-14 days |
| Non-typhoidal Salmonella | Usually no antibiotics (immunocompromised: ciprofloxacin) |
| Vibrio cholerae | Doxycycline single dose (or azithromycin) |
| C. difficile | Vancomycin 125 mg QDS x 10 days OR fidaxomicin 200 mg BD x 10 days |
| Giardia lamblia | Metronidazole 400 mg TDS x 5-7 days |
| E. histolytica | Metronidazole followed by luminal agent (paromomycin) |
| Cryptosporidium | Nitazoxanide (immunocompetent); immune reconstitution in HIV |
Loose Stools
|
├─> Assess dehydration → ORS (Plan A/B) or IV fluids (Plan C)
|
├─> Red flags? (Bloody stool, fever, >10 stools/day, immunocompromised)
| YES → Stool culture + targeted antibiotics
| NO → Supportive care (ORS, zinc, diet)
|
├─> Duration >3 days or travel → Stool culture, parasite tests
|
├─> Antibiotic history / nosocomial → C. diff toxin assay
|
└─> STEC suspected → No antibiotics (risk of HUS)